Celecoxib versus placebo as an adjunct to treatment-as-usual in children and youth with obsessive-compulsive disorder: protocol for a single-site randomised quadruple-blind phase II study.
Clara Westwell-RoperJohn R BestDean ElbeMegan MacFaddenSusan BaerLori TuckerAntony AuZainab NaqqashBoyee LinCynthia LuS Evelyn StewartPublished in: BMJ open (2022)
NCT04673578.
Keyphrases
- obsessive compulsive disorder
- phase ii study
- open label
- placebo controlled
- young adults
- double blind
- clinical trial
- deep brain stimulation
- helicobacter pylori
- phase iii
- randomized controlled trial
- locally advanced
- mental health
- study protocol
- physical activity
- helicobacter pylori infection
- squamous cell carcinoma
- combination therapy
- replacement therapy